{"id":593311,"date":"2026-07-19T09:59:37","date_gmt":"2026-07-19T09:59:37","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/593311\/"},"modified":"2026-07-19T09:59:37","modified_gmt":"2026-07-19T09:59:37","slug":"private-equity-ownership-tilted-healthcare-towards-shareholder-returns","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/593311\/","title":{"rendered":"Private equity ownership tilted healthcare towards shareholder returns"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2026\/07\/1784455177_503_1x1_spacer.png\" alt=\"The increasing influence of global financial capital makes regulatory oversight more difficult and places shareholder interests at the centre of decision-making, according to a study\" title=\"The increasing influence of global financial capital makes regulatory oversight more difficult and places shareholder interests at the centre of decision-making, according to a study\" data-original=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2026\/07\/1784455177_503_1x1_spacer.png\" class=\"article-pictue\"\/><\/p>\n<p class=\"caption\">\n\t\t\t\t\t\t\t\t\t\tThe increasing influence of global financial capital makes regulatory oversight more difficult and places shareholder interests at the centre of decision-making, according to a study<br \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t| Photo Credit:<br \/>\n\t\t\t\t\t\t\t\t\t\t\turfinguss\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n<p>The rapid influx of foreign private equity into India\u2019s healthcare sector has transformed ownership patterns across hospitals, cancer care networks, fertility clinics and medical device companies, prompting  concerns among public health experts that financial returns are increasingly taking precedence over patient care.<\/p>\n<p>A businessline analysis showed that global investors now hold significant stakes across some of India\u2019s largest healthcare providers. Several have moved beyond minority financial investments to controlling ownership.<\/p>\n<p>Investor Grip<\/p>\n<p>The trend extends far beyond hospitals. Private equity capital has also flowed into fertility chains such as Indira IVF, Nova IVF and Oasis Fertility, cancer care providers, medical device manufacturers and healthcare technology companies.<\/p>\n<p>The growing presence of financial investors across the healthcare ecosystem reflects what Dr Indranil, Professor at the School of Government and Public Policy at OP Jindal Global University, describes as the increasing \u201ccorporatisation and financialisation\u201d of healthcare.<\/p>\n<p><img src-template=\"https:\/\/bl-i.thgim.com\/public\/news\/zr7iy\/article71228530.ece\/alternates\/FREE_660\/BL16_Health_equity.jpg\" data-original=\"https:\/\/bl-i.thgim.com\/public\/news\/zr7iy\/article71228530.ece\/alternates\/FREE_660\/BL16_Health_equity.jpg\" alt=\"\" data-device-variant=\"FREE~FREE~FREE~FREE\" class=\" lazy\" width=\"100%\" height=\"100%\"\/><\/p>\n<p>According to Indranil, the key distinction between community-based healthcare providers and corporate hospital chains lies in the role of finance. While independent practitioners and smaller nursing homes are largely driven by medical considerations and local community relationships, large corporate hospitals increasingly operate under pressure to generate returns for investors.<\/p>\n<p>\u201cThe defining feature of these corporate hospitals is that they depend on investments from the financial sector. Investors expect relatively quick financial returns, and that changes institutional priorities.\u201d<\/p>\n<p>He argued that once revenue growth becomes a central objective, hospitals face incentives to maximise billable procedures and high-value interventions. This can potentially influence treatment choices, reduce doctors\u2019 professional autonomy and increase healthcare costs for patients.<\/p>\n<p>Foreign Influence<\/p>\n<p>His recent study highlighted another emerging concern: the growing share of corporate hospitals owned by investors based outside India. According to the study, the increasing influence of global financial capital makes regulatory oversight more difficult and places shareholder interests at the centre of decision-making.<\/p>\n<p>\u201cGovernance of finance imposes the dominance of shareholders\u2019 concerns, and hence interests with excessive focus on maximising shareholders\u2019 returns, and priorities of patients are likely to be compromised,\u201d it said.<\/p>\n<p>Dr Prachinkumar Ghodajkar, an Assistant Professor at the Centre of Social Medicine and Community Health at JNU, said global experience suggests that healthcare should remain the state\u2019s responsibility because it is a public good. \u201cIf you make it something that is sold, purchased and bought by people, then it would have implications not just for the poor but for everyone, and this is what is happening in the US,\u201d he said.<\/p>\n<p>Referring to the US healthcare system, Ghodajkar said much of it is run by the corporate sector through insurance. He said one of the leading causes of death in the country is iatrogenesis \u2014 deaths resulting from medical interventions. \u201cIf you push for this kind of health system, where corporatisation and private equity funds dominate the private sector, it will push providers towards greater profit generation. That would lead to more unnecessary medical care and more deaths,\u201d he added.<\/p>\n<p>Professor Mathew George of the Central University of Kerala said patients were already experiencing the catastrophic financial consequences of these structural changes. As hospitals expanded and became more investment-driven, treatment costs had risen sharply, often outpacing insurance coverage.<\/p>\n<p>\u201cA \u20b95-lakh insurance cover, which was considered adequate a few years ago, is now often exhausted in a single hospitalisation,\u201d he said.<\/p>\n<p class=\"publish-time\" id=\"end-of-article\">Published on  July 15, 2026 <\/p>\n","protected":false},"excerpt":{"rendered":"The increasing influence of global financial capital makes regulatory oversight more difficult and places shareholder interests at the&hellip;\n","protected":false},"author":2,"featured_media":593312,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[275],"tags":[18,135,475,474,7005,19,17,251403,14217,37634,251402],"class_list":["post-593311","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-eire","tag-health","tag-health-care","tag-healthcare","tag-hospitals","tag-ie","tag-ireland","tag-ivf-centres","tag-medical-bills","tag-medical-insurance","tag-private-equity-ownership"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116946061013443184","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/593311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=593311"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/593311\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/593312"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=593311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=593311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=593311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}